CATALYST DOSSIER · UPDATED 2026-11-06
$CECO
industrials · convergence -15 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $CECO?
Quantitative
Net Income (CY2026Q2) : $-34.8M (-465.6% YoY)
Catalysts
Multi-spoke convergence : 8 convergent signals fired: sc13d, congress, uplist, auto_macro_adp_payrolls, auto_macro_bls_employment
Risks
Position-sizing discipline : Conviction AVOID (-15 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, industrials-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
NXPI via semis r=+0.85 sympathetic (score 9)
NVDA via semis r=+0.85 sympathetic (score 8)
QBTS via tech r=+0.75 sympathetic (score 7)
ORBS via tech r=+0.75 sympathetic (score 4)
MRNA via biotech r=+0.62 sympathetic (score 44)
ANIK via biotech r=+0.62 sympathetic (score 15)
Signals Firing
sc13d congress uplist auto_macro_adp_payrolls auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-20 sec_top_gappers +4.1% -0.7% ✓ hit 2026-10-20 sec_top_moat_emerging +4.1% -0.7% ✓ hit 2026-10-19 sec_top_gappers +2.1% +2.1% ✓ hit 2026-10-19 sec_top_moat_emerging +2.1% +2.1% ✓ hit 2026-10-16 sec_top_gappers +5.0% +1.4% ✓ hit 2026-10-16 sec_top_moat_emerging +5.0% +1.4% ✓ hit
Lifetime: 6/6 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket NXPI via semis · score 9 NVDA via semis · score 8 QBTS via tech · score 7 ORBS via tech · score 4 MRNA via biotech · score 44 ANIK via biotech · score 15
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.